(Reuters) — Monsanto Co., the world’s largest seed company, reported a narrower loss for the fourth quarter on Wednesday, and said gains in corn and soybean sales helped it outperform its own forecast for the year.
“We’re confident in our ability to deliver the targets we’ve set in both the near term and over the longer term,” said Monsanto Chief Executive Hugh Grant in a statement.
Still, shares fell after Monsanto, known for its genetically engineered corn, soybeans and other crops as well as the popular Roundup herbicide, said it expects to achieve earnings per share in a range of US $5.75 to $6.00 in fiscal year 2015, lower than the $6.03 per share analysts were expecting.
Read Also

Farm cash receipts rise in first half of 2025 on livestock gains
Farm cash receipts in the first half of the year were up 3.3 per cent over the same period last year buoyed by livestock receipts. Overall receipts between January and June totalled $49.6 billion, up $1.6 billion from the same period last year, Statistics Canada reported.
Monsanto said profits will be impacted by increasing investments in new technology platforms in 2015. One new area of growth is the company’s new farm data business unit.
Edward Jones analyst Matt Arnold said there were no surprises in the fourth-quarter results and investors were squarely focused on the year ahead. Even with grain prices depressed, Monsanto’s premium seed products should continue to be popular with farmers, he said.
“We think that fiscal ’15 can play out reasonably well even in a pretty challenging agricultural environment,” Arnold said.
Monsanto said operating expenses were 15 percent higher in the quarter ended Aug. 31 compared with a year ago, but revenues totalled $2.6 billion, up from $2.2 billion a year ago.
Monsanto said its loss narrowed to $156 million, or 31 cents a share, in the fourth quarter, from $249 million, or 47 cents a share, a year earlier. The most recent quarter included a charge of four cents per share related to an environmental settlement.
The share loss on an ongoing basis was 27 cents a share. Analysts, on average, estimated an ongoing loss of 24 cents a share, according to a survey by Thomson Reuters.
Sales of corn seeds and genetic traits remained a key driver, totalling $630 million for the quarter, up from $618 million a year ago.
Soybean seed and trait sales totalled $199 million for the quarter, up from $87 million a year earlier. The agricultural productivity business unit, which includes Roundup herbicide, reported net sales of $1.25 billion, up from $1 billion a year earlier.
Net sales for the full year totalled $15.9 billion, up seven percent from 2013, helped in part by record soybean sales for the year of $2.1 billion.
In June, Monsanto forecast full-year ongoing earnings at $5.10 to $5.20 a share. The company said it beat the high end of that range with 2014 ongoing earnings of $5.23 a share.